NKGen Biotech- Warrants (01/09/2028) Other Current Liabilities

The latest other current liabilities for NKGNW is $39M as of March 2025. That compares with $13M in the prior-year period — up 205.3% year over year. Investors often review this figure alongside NKGen Biotech- Warrants (01/09/2028)'s historical trend and sector peers before judging valuation or financial health.

Over the past year, NKGNW's other current liabilities moved from $13M to $39M — a 205.3% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in NKGen Biotech- Warrants (01/09/2028)'s operating scale or balance-sheet position.

A other current liabilities figure of $39M for NKGNW is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting NKGNW's other current liabilities ($39M), review year-over-year change from $13M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.